Year |
Citation |
Score |
2015 |
Nocjar C, Alex KD, Sonneborn A, Abbas AI, Roth BL, Pehek EA. Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex. Neuroscience. 297: 22-37. PMID 25818050 DOI: 10.1016/J.Neuroscience.2015.03.050 |
0.777 |
|
2015 |
Pehek EA, Hernan AE. Stimulation of glutamate receptors in the ventral tegmental area is necessary for serotonin-2 receptor-induced increases in mesocortical dopamine release. Neuroscience. 290: 159-64. PMID 25637799 DOI: 10.1016/j.neuroscience.2015.01.029 |
0.796 |
|
2014 |
Burke MV, Nocjar C, Sonneborn AJ, McCreary AC, Pehek EA. Striatal serotonin 2C receptors decrease nigrostriatal dopamine release by increasing GABA-A receptor tone in the substantia nigra. Journal of Neurochemistry. 131: 432-43. PMID 25073477 DOI: 10.1111/jnc.12842 |
0.807 |
|
2007 |
Alex KD, Pehek EA. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacology & Therapeutics. 113: 296-320. PMID 17049611 DOI: 10.1016/j.pharmthera.2006.08.004 |
0.384 |
|
2006 |
Pehek EA, Nocjar C, Roth BL, Byrd TA, Mabrouk OS. Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 265-77. PMID 15999145 DOI: 10.1038/sj.npp.1300819 |
0.803 |
|
2005 |
Alex KD, Yavanian GJ, McFarlane HG, Pluto CP, Pehek EA. Modulation of dopamine release by striatal 5-HT2C receptors. Synapse (New York, N.Y.). 55: 242-51. PMID 15668911 DOI: 10.1002/syn.20109 |
0.692 |
|
2004 |
Saklayen SS, Mabrouk OS, Pehek EA. Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors. The Journal of Pharmacology and Experimental Therapeutics. 311: 342-8. PMID 15175419 DOI: 10.1124/jpet.104.067991 |
0.361 |
|
2003 |
Saklayen S, Kirkbride B, Maniar N, Mabrouk O, Pehek E. A comparison of the effects of risperidone and its major metabolite, 9-hydroxy-risperidone, on dopamine release in the rat prefrontal cortex Schizophrenia Research. 60: 114. DOI: 10.1016/S0920-9964(03)80866-6 |
0.384 |
|
2002 |
Mazei MS, Pluto CP, Kirkbride B, Pehek EA. Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat. Brain Research. 936: 58-67. PMID 11988230 DOI: 10.1016/S0006-8993(02)02542-8 |
0.372 |
|
2002 |
Nocjar C, Roth BL, Pehek EA. Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group. Neuroscience. 111: 163-76. PMID 11955720 DOI: 10.1016/S0306-4522(01)00593-0 |
0.778 |
|
2001 |
Jaskiw GE, Collins KA, Pehek EA, Yamamoto BK. Tyrosine augments acute clozapine- but not haloperidol-induced dopamine release in the medial prefrontal cortex of the rat: an in vivo microdialysis study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 149-56. PMID 11377928 DOI: 10.1016/S0893-133X(01)00220-2 |
0.4 |
|
2001 |
Pehek EA, McFarlane HG, Maguschak K, Price B, Pluto CP. M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex. Brain Research. 888: 51-59. PMID 11146051 DOI: 10.1016/S0006-8993(00)03004-3 |
0.639 |
|
1999 |
Pehek EA. Comparison of effects of haloperidol administration on amphetamine-stimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum. The Journal of Pharmacology and Experimental Therapeutics. 289: 14-23. PMID 10086982 |
0.416 |
|
1997 |
Pehek EA, Bi Y. Ritanserin administration potentiates amphetamine-stimulated dopamine release in the rat prefrontal cortex. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 21: 671-82. PMID 9194148 DOI: 10.1016/S0278-5846(97)00040-7 |
0.473 |
|
1997 |
Pehek EA, Schaldach MA. Comparison of intracortical versus intrastriatal infusions of D1 and D2 antagonists on extracellular dopamine levels in the rat Schizophrenia Research. 24: 81. DOI: 10.1016/S0920-9964(97)82219-0 |
0.315 |
|
1996 |
Pehek EA. Local infusion of the serotonin antagonists ritanserin or ICS 205,930 increases in vivo dopamine release in the rat medial prefrontal cortex. Synapse (New York, N.Y.). 24: 12-8. PMID 9046072 DOI: 10.1002/(SICI)1098-2396(199609)24:1<12::AID-SYN2>3.0.CO;2-J |
0.439 |
|
1995 |
Pehek E. Systemic and intracortical administration of ritanserin increases in vivo dopamine release in rat prefrontal corteX Schizophrenia Research. 15: 161. DOI: 10.1016/0920-9964(95)95500-9 |
0.387 |
|
1994 |
Pehek EA, Yamamoto BK. Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen. Journal of Neurochemistry. 63: 2118-24. PMID 7964731 DOI: 10.1046/J.1471-4159.1994.63062118.X |
0.396 |
|
1994 |
Yamamoto BK, Pehek EA, Meltzer HY. Brain region effects of clozapine on amino acid and monoamine transmission. The Journal of Clinical Psychiatry. 55: 8-14. PMID 7961581 |
0.331 |
|
1993 |
Pehek EA, Meltzer HY, Yamamoto BK. The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux. European Journal of Pharmacology. 240: 107-9. PMID 8405119 DOI: 10.1016/0014-2999(93)90555-V |
0.501 |
|
1993 |
Pehek E, Yamamoto B. Comparison of locally administered haloperidol and clozapine on dopamine efflux in the rat brain Schizophrenia Research. 9: 226. DOI: 10.1016/0920-9964(93)90494-4 |
0.379 |
|
1992 |
Pehek EA, Crock R, Yamamoto BK. Selective subregional dopamine depletions in the rat caudate-putamen following nigrostriatal lesions. Synapse (New York, N.Y.). 10: 317-25. PMID 1374937 DOI: 10.1002/Syn.890100406 |
0.423 |
|
1991 |
Pehek E, Yamamoto B, Meltzer H. The effects of clozapine on dopamine, 5-HT, and glutamate release in the rat medial prefrontal cortex Schizophrenia Research. 4: 323-324. DOI: 10.1016/0920-9964(91)90222-D |
0.392 |
|
1990 |
Pehek EA, Schechter MD, Yamamoto BK. Effects of cathinone and amphetamine on the neurochemistry of dopamine in vivo. Neuropharmacology. 29: 1171-6. PMID 2293059 DOI: 10.1016/0028-3908(90)90041-O |
0.403 |
|
1990 |
Yamamoto BK, Pehek EA. A neurochemical heterogeneity of the rat striatum as measured by in vivo electrochemistry and microdialysis. Brain Research. 506: 236-42. PMID 2137360 DOI: 10.1016/0006-8993(90)91256-G |
0.437 |
|
1989 |
Pehek EA, Thompson JT, Hull EM. The effects of intracranial administration of the dopamine agonist apomorphine on penile reflexes and seminal emission in the rat. Brain Research. 500: 325-32. PMID 2605500 DOI: 10.1016/0006-8993(89)90328-4 |
0.745 |
|
1989 |
Pehek EA, Thompson JT, Hull EM. The effects of intrathecal administration of the dopamine agonist apomorphine on penile reflexes and copulation in the male rat. Psychopharmacology. 99: 304-8. PMID 2574477 DOI: 10.1007/BF00445548 |
0.737 |
|
1988 |
Pehek EA, Warner RK, Bazzett TJ, Bitran D, Band LC, Eaton RC, Hull EM. Microinjection of cis-flupenthixol, a dopamine antagonist, into the medial preoptic area impairs sexual behavior of male rats. Brain Research. 443: 70-6. PMID 3359281 DOI: 10.1016/0006-8993(88)91599-5 |
0.766 |
|
1988 |
Pehek EA, Thompson JT, Eaton RC, Bazzett TJ, Hull EM. Apomorphine and haloperidol, but not domperidone, affect penile reflexes in rats. Pharmacology, Biochemistry, and Behavior. 31: 201-8. PMID 3252251 DOI: 10.1016/0091-3057(88)90334-6 |
0.801 |
|
1988 |
Hull EM, Pehek EA, Bitran D, Holmes GM, Warner RK, Band LC, Bazzett T, Clemens LG. Brain localization of cholinergic influence on male sex behavior in rats: antagonists. Pharmacology, Biochemistry, and Behavior. 31: 175-8. PMID 3252248 DOI: 10.1016/0091-3057(88)90330-9 |
0.69 |
|
1988 |
Hull EM, Bitran D, Pehek EA, Holmes GM, Warner RK, Band LC, Clemens LG. Brain localization of cholinergic influence on male sex behavior in rats: agonists. Pharmacology, Biochemistry, and Behavior. 31: 169-74. PMID 3252247 DOI: 10.1016/0091-3057(88)90329-2 |
0.776 |
|
1986 |
Hull EM, Bitran D, Pehek EA, Warner RK, Band LC, Holmes GM. Dopaminergic control of male sex behavior in rats: effects of an intracerebrally-infused agonist. Brain Research. 370: 73-81. PMID 3011196 DOI: 10.1016/0006-8993(86)91106-6 |
0.787 |
|
Show low-probability matches. |